TOVX
#4763
Theriva Biologics, Inc. Common Stock
0.2 1 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-16.00%
6 month change
-15.19%
Year Change
-15.19%
Previous Close
0.2 1
Open
0.2 2
Low
0.2 1
High
0.2 2
Volume
28
Financials
- Market Capitalization 9.64 M
- Employee 16
- Founded 1986
- CEO N/A
- Website www.therivabio.com
- Headquarter Nevada, United States
- FIGI BBG000BV6QX8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.1
Price to sales ratio
102.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4758 |  VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.24 USD | 0.00% | +9.09% | +9.09% | -53.41% | 9.85 M USD | ||
| 4762 |  CRIS Curis, Inc. - Common Stock | 4.96 USD | -0.40% | -0.40% | +853.85% | +198.80% | 9.67 M USD | ||
| 4773 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.03 USD | -5.50% | -51.18% | -69.44% | -58.30% | 9.38 M USD | ||
| 4780 |  LNAI Lunai Bioworks Inc. - Common Stock | 2.02 USD | -4.27% | -15.48% | -38.41% | +30.32% | 9.16 M USD |
Frequently asked questions about Theriva Biologics, Inc. Common Stock
What is the Theriva Biologics, Inc. Common Stock stock price today?
The current price of Theriva Biologics, Inc. Common Stock (TOVX) is 0.21. Over the past 24 hours, the stock has changed by 0.00%. Follow the TOVX chart for real-time price dynamics.
What is the stock ticker of Theriva Biologics, Inc. Common Stock?
Theriva Biologics, Inc. Common Stock trades under the ticker TOVX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Theriva Biologics, Inc. Common Stock stock going up?
TOVX has changed by -4.55% over the last week, -16.00% over the last month, and -15.19% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Theriva Biologics, Inc. Common Stock?
Theriva Biologics, Inc. Common Stock currently has a market capitalization of 9.64 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Theriva Biologics, Inc. Common Stock release financial reports?
Yes. You can track Theriva Biologics, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Theriva Biologics, Inc. Common Stock earnings last quarter?
Last quarter, Theriva Biologics, Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Theriva Biologics, Inc. Common Stock revenue for the last quarter?
Theriva Biologics, Inc. Common Stock reported quarterly revenue of 300 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Theriva Biologics, Inc. Common Stock net income for the last quarter?
Theriva Biologics, Inc. Common Stock reported net income of -2.04 M for the last quarter. The previous quarter showed -2 M, which means net income changed by -2.40%.
How many employees does Theriva Biologics, Inc. Common Stock have?
As of the latest available data, Theriva Biologics, Inc. Common Stock has 16 employees. Workforce size can provide additional context about the company's scale and operations.
What is Theriva Biologics, Inc. Common Stock EBITDA?
Theriva Biologics, Inc. Common Stock EBITDA is -2.1 M, and its EBITDA margin is -701%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Theriva Biologics, Inc. Common Stock stock?
You can buy Theriva Biologics, Inc. Common Stock (TOVX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Theriva Biologics, Inc. Common Stock stock?
Investing in Theriva Biologics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TOVX chart and related analysis on metatrader.com as part of your research.